Female sexual dissatisfaction: Hormone therapy inappropriate

Prescrire International

Volumn 16, Issue 91, 2007, Pages 202-205

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANDROGEN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CYTOTOXIC AGENT; ESTROGEN; MELATONIN; ORAL CONTRACEPTIVE AGENT; PLACEBO; PRASTERONE; SEROTONIN UPTAKE INHIBITOR; SEX HORMONE; SILDENAFIL; TESTOSTERONE; TIBOLONE;

ATTITUDE TO SEXUALITY; CANCER RISK; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CORRELATION ANALYSIS; CULTURAL FACTOR; DRUG EFFICACY; DRUG INDICATION; DRUG SAFETY; EVIDENCE BASED MEDICINE; FEMALE SEXUAL DISSATISFACTION; FEMALE SEXUAL DYSFUNCTION; HORMONAL THERAPY; HUMAN; HUMAN RELATION; INTIMACY; LABORATORY TEST; MASS MEDIUM; MEDICAL LITERATURE; MENOPAUSE; MONOTHERAPY; PATIENT EDUCATION; POSTMENOPAUSE; PSYCHOLOGICAL ASPECT; PSYCHOLOGICAL WELL BEING; PSYCHOSEXUAL DISORDER; PSYCHOTHERAPY; REVIEW; RISK BENEFIT ANALYSIS; SEXUAL AROUSAL DISORDER; SEXUAL BEHAVIOR; SEXUAL DYSFUNCTION; SEXUAL FUNCTION; SEXUAL SATISFACTION; SIDE EFFECT; TESTOSTERONE SYNTHESIS; UNSPECIFIED SIDE EFFECT; VAGINAL DRYNESS;

AUSTRALIA; DRUG THERAPY, COMBINATION; ESTROGENS; FEMALE; GREAT BRITAIN; HORMONE REPLACEMENT THERAPY; HUMANS; LIBIDO; MENOPAUSE; NEW ZEALAND; ORGASM; PERSONAL SATISFACTION; PIPERAZINES; PROGESTERONE; PSYCHOTHERAPY; PURINES; RANDOMIZED CONTROLLED TRIALS; SEXUAL DYSFUNCTIONS, PSYCHOLOGICAL; SEXUALITY; SULFONES; TESTOSTERONE; UNITED STATES;

EID: 34948829188     PISSN: 11677422     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (31)

1. Alperstein L et al. "A new view of women's sexual problems" manifesto. Website www.fsd-alert.org consulted on 15 January 2007: 6 pages.
2. Tiefer L "Female sexual dysfunction: a case study of disease mongering and activist resistance" PLoS Med 2006; 3 (4): 436-440.
3. Basson R "Clinical practice. Sexual desire and arousal disorders in women" N Eng J Med 2006,354 (14): 1497-1506.
4. Bancroft J et al. "Distress about sex: a national survey of women in heterosexual relationship" Arch Sex Behav 2003; 32 (3): 193-208.
5. Hite S "Le nouveau rapport Hite. L'enquête la plus révolutionnaire jamais menée sur la sexualité féminine" J'ai lu, Paris 2004: 890 pages.
6. Walsh KE and Berman J "Sexual dysfunction in the older woman. An overview of the current understanding and management" Drugs Aging 2004, 21 (10): 655-675.
7. e éd., Masson, Paris 2003: 617-653.
8. Basson R "Sexual concerns. Menopause and sexual function". in: "Canadian consensus conference on menopause, 2006 update" J Obstet Gynaecol Can 2006; 28 (special ed.): 43-52.
9. Laumann EO et al. "Sexual dysfunction in the United States. Prevalence and predictors" JAMA 1999; 281(6): 537-544.
10. Mercer CH et al. "Sexual function problems and help seeking behaviour in Britain: national probability sample survey" BMJ 2003; 327:426-427.
11. Avis NE et al. "Correlates of sexual function among multi-ethnic middle-aged women, results from the study of women's health across the nation SWAN" Menopause 2005; 12 (4): 385-398.
12. Basson R and Schultz WW "Sexual sequelae of general medical disorders" Lancet 2007; 309: 409-424.
13. "Sexual health - a new focus for WHO" Progress 2004, 67: 1-7.
14. Moynihan R "The marketing of a disease: female sexual dysfunction" BMJ 2005; 330: 192-194.
15. Prescrire Editorial Staff "Melatonine" Prescrire Int 1998; 7(38): 180-187.
16. Prescrire Editorial Board "DHEA. La nouvelle esbroufe" Rev Prescrire 2002; 22 (227): 283-290 + 22 (228): II de couverture
17. Arlt W "Androgen therapy in women" Eur J Endoctinol 2006; 154: 1-11.
18. Prescrire Editorial Staff "No androgen for sexual dysfunction after menopause" Prescrire Int 2002; 11 (59): 81.
19. Somboonporn W et al. "Testosterone for peri- and postmenopausal women" (Cochrane Review) (dernièe révision: 2005). In: "The Cochrane library" John Wiley and Sons, Chichester 2006; issue 2: 122 pages.
20. "The role of testosterone therapy in post-menopausal women: position statement of the North American Menopause Society" Menopause 2005; 12 (5): 497-511.
21. O'Donohue W et al. "Psychotherapy for female sexual dysfunction: a review" Clin Psychol Rev 1997; 17 (5): 537-566.
22. Trudel G et al. "The effect of a cognitive-behavioral group treatment program on hypoactive sexual desire in women" Sex Relat Ther 2001; 16 (2): 145-164.
23. Modelska K and Cummings S "Female sexual dysfunction in postmenopausal women: systematic review of placebo-controlled trials" Am J Obstet Gynecol 2003; 188 (1): 286-293.
24. Prescrire Editorial Staff Postmenopausal hormone replacement therapy (continued)" Prescrire Int 2004; 13 (71): 106-109.
25. Prescrire Rédaction "Hormonothérapie de la ménopause et cancers du sein: une évaluation française" Rev Prescrire 2005; 25 (267): 829.
26. Prescrire Editorial Staff "Tibolone: cancers of the breast and endometrium" Prescrire Int 2006; 15(83): 107.
27. o" Rev Prescrire 1997; 17 (177): 636-638.
28. Basson R et al. "Efficacy and safety of sildenafil citrate in women with sexual dysfunction associated with female sexual arousal disorder" J Womens Health Gend Based Med 2002; 11(4): 367-377.
29. Mayor S "Pfizer will not apply for a licence for sildenafil for women BMJ 2004, 328: 542.
30. Tamimi RM et al. "Combined estrogen and testosterone use and risk of breast cancer in postmenopausal women Arch Intern Med 2006; 166: 1483-1489.
31. Hudita D et al. Efficacy and safety of oral tibolone 1.25 or 2.5 mg/day vs placebo in postmenopausal women Eur Rev Med Pharmacol Sci 2003; 7: 117-125.